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Background: Vasopressin is widely used to treat various type of hypotension, but the effect of vasopressin on
coronary artery bypass grafting surgery (CABG) patients is not clear. This study was to investigate the effect of
vasopressin on the hemodynamics in CABG patients.
Methods: Twenty coronary artery disease (CAD) patients were randomly divided into two groups: norepinephrine
group and vasopressin group. During the anesthesia and the operation, the central venous pressure (CVP) and
pulmonary capillary wedge pressure (PCWP) were maintained to 8-10cmH2O, and the hemocrit was maintained
above 30% through lactate ringer’s mixture, artifact colloid and red blood cells. The invasive artery blood pressure
(IBP) was maintained by appropriate anesthetic depth and norepinephrine or vasopressin respectively. The target
IBP was 70 mmHg, and heart rate (HR) was 60 bpm. The MAP (mean artery pressure), HR, ST-T, CVP, PAP (pulmonary
artery pressure), PCWP, SVR (systemic vascular resistance), PVR (pulmonary vascular resistance), CO (cardiac output),
urine output, blood gas analysis, surgery duration and blood loss were monitored.
Results: The MAP, HR, and ST-T were stable in either group during the operation. CVP, PCWP and SVR increased
but CI deceased during the posterior descending artery (PDA) was grafted in both groups and without any
significant difference between them. PAP increased during PDA was grafted in either group and there was
significant difference between the two groups. PVR increased during ADA and PDA being grafted in
norepinephrine group but not in vasopressin group. Metoprolol usage was 11.2 mg and 5.9 mg in norepinephrine
group and vasopressin group respectively.
Conclusion: Vasopressin was better than norepinephrine.to keep the hemodynamics stability of patients
undergoing CABG surgery.
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Coronary artery bypass grafting surgery (CABG) is a
complicated surgery. The hemodynamics will be dramat-
ically fluctuated during the operation. It is inevitable to
use a series of vasoactive drugs such as norepinephrine,
phenylephrine during CABG. However, there are several
studies reported that hemodynamic abnormalities was
corrected by using non-catecholamine drugs. Vasopressin
has potential vasoconstriction effect and it could increase
the afterload of the heart, therefore decreasing the cardiac
output. However, the previous studies demonstrated that
vasopressin could improve left ventricular function [1]* Correspondence: liningrigs@vip.sina.com
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reproduction in any medium, provided the orand exactly increase the cardiac output and the coronary
blood flow, which was ultimately due to the increase of
coronary perfusion pressure [2].
Some studies have indicated that vasopressin could
ameliorate hypotension effectively during some surgeries
[3], especially for those patients unresponsive to norepin-
ephrine, phenylephrine and other catecholamine vasoactive
drugs. Therefore, this study was designed to investigate
the effect of vasopressin on the hemodynamics during
CABG surgeries.Methods
The study protocol followed the Declaration of Helsinki
and was approved by the Ethics and Research Committee
of Nanjing University (Nanjing, P.R. China). The studytd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 A: MAP changes in the two groups. B: HR changes in the two groups. C: CVP changes in the two groups. D: PAP changes in the two
groups. MAP: mean artery pressure, HR: heart rate, CVP: central venous pressure, PAP: pulmonary artery pressure. *P < 0.05, **P < 0.01 VS baseline.
#P < 0.05,##P < 0.01 within the groups.
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all the patients signed written informed consents.
Twenty coronary artery disease (CAD) patients undergo-
ing selective CABG surgeries were enrolled in this study.
Patients with preoperative unstable conditions such as se-
vere arrhythmia, heart failure or cardiogenic shock, blood
pressure unstability, diabetes mellitus, pulmonary disease,
valvular disease, pulmonary hypertension were excluded inFigure 2 A: PCWP changes in the two groups. B: SVR changes in the tw
groups. PCWP: pulmonary capillary wedge pressure, SVR: systemic vascular
*P < 0.05, **P < 0.01 VS baseline. #P < 0.05,##P < 0.01 within the groups.this study. Patients with significant pathological changes in
the liver and renal function and needing emergency
cardiopulmonary bypass should also be excluded.
All the patients were monitored with ECG, IBP, SpO2
after they entered the operating rooms. Anesthesia
induction program: midazolam 0.05 mg/kg, etomidate
0.1-0.2 mg/kg, vecuronium bromide 0.15 mg/kg, fentanyl
5-10 ug/kg. Then central venous and Swan-ganz catheterso groups. C: PVR changes in the two groups. D: CI changes in the two
resistance, PVR: pulmonary vascular resistance, CI: cardiac index.
Table 1 Artery blood gas analysis during the two groups
PH PO2 PCO2 BE HB Na K iCa
vasopressin group
Baseline 7.36 ± 0.09 479 ± 33 42 ± 2.2 −1 ± 0.9 13.8 ± 3.5 139 ± 9 3.7 ± 0.2 1.15 ± 0.15
After induction of anesthesia 7.33 ± 0.11 509 ± 35 44 ± 2.5 0 ± 0.4 13.1 ± 3.3 133 ± 8 3.6 ± 0.5 1.11 ± 0.11
5 min after surgical incision 7.39 ± 0.11 516 ± 21 45 ± 1.9 −2 ± 0.6 12.9 ± 2.5 135 ± 9 3.3 ± 0.3 1.15 ± 0.21
5 min after Sternotomy 7.40 ± 0.12 467 ± 22 42 ± 2.6 −1 ± 0.9 10.5 ± 2.2* 136 ± 8 3.8 ± 0.5 1.06 ± 0.22
During ADA grafting 7.30 ± 0.08 444 ± 20 39 ± 3.2 −2.5 ± 1.1 11.1 ± 3.7* 139 ± 7 3.9 ± 0.3 1.08 ± 0.30
During PDA grafting 7.41 ± 0.07 489 ± 31 44 ± 3.2 −1 ± 0.2 11.0 ± 2.3* 138 ± 7 4.2 ± 0.4 1.22 ± 0.11
The end of surgery 7.39 ± 0.07 501 ± 33 43 ± 2.6 −2 ± 0.3 12.9 ± 2.6 142 ± 6 3.9 ± 0.2 1.25 ± 0.09
norepinephrine group
Baseline 7.33 ± 0.11 523 ± 30 45 ± 2.2 0 ± 0.6 12.1 ± 2.8 143 ± 6 3.6 ± 0.2 1.21 ± 0.08
After induction of anesthesia 7.36 ± 0.10 498 ± 28 45 ± 2.7 −2 ± 0.9 11.9 ± 1.9 139 ± 5 3.8 ± 0.4 1.15 ± 0.12
5 min after surgical incision 7.41 ± 0.12 489 ± 26 43 ± 3.2 −2 ± 1.0 10.0 ± 1.5* 135 ± 7 3.9 ± 0.3 1.16 ± 0.11
5 min after Sternotomy 7.40 ± 0.13 465 ± 27 41 ± 3.6 −1.5 ± 1.0 11.5 ± 1.6* 137 ± 8 4.2 ± 0.3 1.18 ± 0.12
During ADA grafting 7.41 ± 0.12 489 ± 26 43 ± 3.2 −2 ± 1.0 10.0 ± 1.5* 135 ± 7 3.9 ± 0.3 1.16 ± 0.11
During PDA grafting 7.40 ± 0.13 465 ± 27 41 ± 3.6 −1.5 ± 1.0 11.5 ± 1.6* 137 ± 8 4.2 ± 0.3 1.18 ± 0.12
The end of surgery 7.42 ± 0.09 500 ± 22 45 ± 3.2 0 ± 0.5 11.0 ± 1.8* 139 ± 9 4.4 ± 0.5 1.24 ± 0.13
*P < 0.05 VS baseline.
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6-10 mg/kg/h, atracurium 5-10 ug/kg/min, fentanyl
intermittently. The total fentanyl dosage was controlled
to 30-50 ug/kg. The anesthesiologists, surgeons, nurses
and the statistician were blinded to the protocol. Patients
were randomly divided into two groups by a computer
program. Ten patients were administered norepinephrine
and the others were administered vasopressin in the
presence of hypotension during the operation. Using
Ringer's lactate, artificial colloidal and red blood cells to
maintain CVP and PCWP, to keep HCT not less than
30%, and to obtain IBP 70-90 mmHg,HR 55-65 bpm. IBP,
HR, ST-T, CVP, PAP, SVR, PVR, CO, urine output, arterial
blood gas analysis, the operation duration, the amount of
bleeding, drug dosage, beta block usage were recorded.Statistical analysis
The data were analyzed with the software SPSS 13.0.
The quantitative data were expressed as mean ± SD, and
repeated measures analysis was used for hemodynamic
variables. Also, unpaired Student t for difference in artery
blood gas analysis and other quantitative parameters
between the two groups. The qualitative data were
compared with chi-square analysis. Fisher’s exact testTable 2 Other parameters during the two groups
Operation time (h) The amount of bleeding
vasopressin group 4.6 ± 0.6 680 ± 110
norepinephrine group 4.4 ± 0.7 660 ± 99was used when the minimum expected count was less
than five. P < 0.05 was considered to be significant.
Results
There was no significant difference in the age, gender,
BMI, heart function, ASA physical status, baseline MAP
and HR between the two groups. All patients had three
coronary artery lesions and received three grafts. There
was no significant difference in MAP after induction of
anesthesia and during surgery between the two groups.
MAP is higher than that after anesthesia induction but
close to the baseline value at the end of surgery. CVP,
PCWP, SVR and CI increased significantly during PDA
grafting was performed and there was no difference
between groups. PAP and PVR also increased during
PDA grafting was performed and there was difference
between groups. (Figures 1 and 2).
Acid–base balance and blood gas analysis: Hemoglobin
concentration decreased significantly during ADA and
PDA was performed and at the end of surgery, there was
significant difference when compared with that after
anesthesia induction (P < 0.05), however, no significant
difference was found between the two groups (Table 1).
There was no obvious abnormality in ST-T segment,
operation duration, bleeding volume and urine output in(ml) Urine output (ml) Drug dosage Metoprolol dosage mg
1250 ± 202 0.4 ± 0.11 mg 11.2 ± 3.4
1365 ± 189 3.6 ± 1.2 IU 5.9 ± 2.0##
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sin usage was 3.6 IU in vasopressin group and total
norepinephrine usage was 0.48 mg in norepinephrine
group. Metoprolol usage was 5.9 mg in vasopressin group
and 11.2 mg in norepinephrine group (P < 0.01) (Table 2).
Discussion and conclusion
The hemodynamics showed dramatic fluctuation in
CABG patients during the anesthesia and surgery, which
is probably due to its pathophysiological characteristics
and operative factors. In this study, these patients were
poorly tolerated in the presence of both anesthesia and
surgery. Anesthesiologists should maintain the stability
of hemanynamics, so some vasoactive drugs such as
phenylephrine, norepinephrine, and other catecholamine
drugs are inevitably used.
There are three intrinsic vasopressor systems, ie,
sympathetic nervous system, renin- angiotensin system
and vasopressin system. Mounting studies have indicated
that vasopressin was much more potent in cardiopulmo-
nary resuscitation than catecholamines [4]. But for CABG
patients, it was unclear which vasopressor was more
potent and with less side effects.
Our study confirmed that the vasopressin is similar to
the traditional catecholamines to maintain the stability of
hemodynamics, and even superior to the catecholamines
in some aspects, such as pulmonary artery pressure,
metoprololuse usage. Catecholamine hormones could
increase blood pressure, while inevitablely increase
pulmonary vascular resistance, thereby leading to increase
of pulmonary artery pressure. Pulmonary hypertension, as
we know, a very dangerous pathophysiological change,
deteriorate hemodynamic and respiratory function,
meanwhile induce the failure of the entire surgery.
No evidence showed that using of low doses of
vasopressin (0.04 U/min) increased PVR or PAP. On the
contrary, Basic study showed that vasopressin could
decrease PAP [5]. The results of this study suggested
that no pulmonary artery pressure elevation after adminis-
tration of vasopressin, instead, pulmonary artery pressure
is relatively stable in vasopressin group perhaps due to the
better-maintained systemic arterial pressure and less
norepinephrine usage.
Patients undergoing CABG surgery are needed to
maintain a slower heart rate to reduce myocardial oxygen
consumption and facilitate the surgical procedure.
Although CABG patients will have a slower heart rate
during the anesthesia and operation because of pre-
operative β-blockers and anesthetic agents, but the heart
rate still inevitable increase during the surgery and
anesthesiologist need to use the additional beta blockers.
In this study, vasopressin group patients need less beta
blockers but not in norepinephrine group patients. The
reasons may be norepinephrine has positive inotropic andpositive frequency effect and pulmonary pressure is
relatively unstable.
Vasopressin, also known as antidiuretic hormone can
reduce urine output. But this study did not indicate an
obvious decreament in the urine output after treatment
of vasopressin. Enough arterial pressure and cardiac
output can assure enough kidney perfusion and result in
maintained urine output. Antidiuretic hormone can
enhance the kidney collecting duct re-absorption of H2O,
leading to dilutional hyponatremia. Serum sodium and
other electrolytes should be monitored during prolonged
use of vasopressin.
In addition, it was generally believed that high blood
pressure can lead to increased surgical drainage. But in
this study vasopressin increased blood pressure without
increasing the amount of bleeding volume. Some study
demonstrated that the anti-diuretic hormone receptor has
three subtypes, V1, V2 and V3 receptors. V2 receptor
exciting can increase the concentration of plasma coagu-
lation factor VII and vWF. Consequently, researchers have
already proposed: for those patients with reduced plasma
level of factor VIII and vWF such as hemophilia A and
type I von Willebrand disease, anti-diuretic hormone
should be administered during perioperative time [6].
Vasopressin can also cause a transient elevation in
blood glucose and the mechanism is related to the liver
glycogen catabolism by V1 receptor. We recommended
that patients’ blood glucose should be monitored for
prolonged use of vasopressin and those with diabetic
mellitus [7].
In conclusion, vasopressin may be another choice to
deal with hypotension during CABG surgeries.
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